8.035 USD
-0.19 (-2.25%)
ChartMill assigns a Buy % Consensus number of 87% to ORIC. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 20.32. This target is 152.83% above the current price.
ORIC was analyzed by 20 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about ORIC.
In the previous month the buy percentage consensus was at a similar level.
ORIC was analyzed by 20 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-08 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-12-08 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-11-20 | Evercore ISI Group | Initiate | Outperform |
| 2025-11-18 | Wolfe Research | Initiate | Peer Perform |
| 2025-11-18 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-11-17 | Citigroup | Maintains | Buy -> Buy |
| 2025-11-14 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-11-14 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-11-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-08-14 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-08-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-08-13 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-07-08 | Ladenburg Thalmann | Initiate | Buy |
| 2025-05-09 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-05-06 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-05-06 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-05-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-26 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-02-26 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-02-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-10 | Guggenheim | Maintains | Buy -> Buy |
| 2025-02-06 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-01-14 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-01-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-31 | Jones Trading | Initiate | Buy |
| 2024-10-31 | Wells Fargo | Initiate | Overweight |
ORIC PHARMACEUTICALS INC / ORIC FAQ
What do analysts expect the price target to be for ORIC PHARMACEUTICALS INC (ORIC)?
20 analysts have analysed ORIC and the average price target is 20.32 USD. This implies a price increase of 152.83% is expected in the next year compared to the current price of 8.035.
What is the consensus rating for ORIC stock?
The consensus rating for ORIC PHARMACEUTICALS INC (ORIC) is 87 / 100 . This indicates that analysts generally have a positive outlook on the stock.